# Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

> **NCT00645294** · PHASE1,PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 47 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Adefovir dipivoxil
- **DRUG:** Adefovir Dipivoxil
- **DRUG:** Adefovir Dipivoxil

## Key facts

- **NCT ID:** NCT00645294
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2008-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645294, "Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00645294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*